NasdaqGM - Delayed Quote • USD
Sutro Biopharma, Inc. (STRO)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 6:16 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALBINI EDWARD C Chief Financial Officer | Conversion of Exercise of derivative security | Mar 5, 2024 | 106,743 |
| BORGMAN ANNE ELIZABETH Officer | Conversion of Exercise of derivative security | Feb 29, 2024 | 24,374 |
| CHUNG JANE President | Conversion of Exercise of derivative security | Mar 4, 2024 | 42,201 |
| FITZPATRICK LINDA A. Officer | Conversion of Exercise of derivative security | Mar 5, 2024 | 83,335 |
| HALLAM TREVOR C Officer | Conversion of Exercise of derivative security | Apr 14, 2023 | 100,368 |
| NEWELL WILLIAM J Chief Executive Officer | Conversion of Exercise of derivative security | Mar 5, 2024 | 336,728 |
| PETREE DANIEL HUNTER Director | Stock Gift | Jun 27, 2023 | 22,457 |
| SHTYLLA BRUNILDA Officer | Sale | Aug 28, 2023 | -- |
| SRINIVASAN VENKATESH Chief Operating Officer | Conversion of Exercise of derivative security | Apr 11, 2024 | 30,122 |
| VASQUEZ NICKI J Officer | Sale | Jan 29, 2024 | 14,279 |
Related Tickers
BCAB BioAtla, Inc.
2.3500
+4.91%
MRSN Mersana Therapeutics, Inc.
2.8800
-10.28%
ITOS iTeos Therapeutics, Inc.
10.57
-3.82%
ADCT ADC Therapeutics SA
4.7800
-3.82%
SRRK Scholar Rock Holding Corporation
14.09
-4.73%
SYRE Spyre Therapeutics, Inc.
32.99
-3.68%
YMAB Y-mAbs Therapeutics, Inc.
15.29
-0.33%
SGMT Sagimet Biosciences Inc.
4.1700
-2.57%
STOK Stoke Therapeutics, Inc.
11.66
+3.64%
REPL Replimune Group, Inc.
6.33
-1.40%